This Breast Cancer Awareness Month, please consider supporting the Breast Cancer Innovation Foundation (BCIF). Every donation is tax deductible!

The BCIF is aiming to raise two million dollars to finance the small-scale clinical trial of a new breast implant cover infused with the Doxorubicin chemotherapy drug that would provide targeted, local chemotherapy to breast tissue post-reconstructive surgery.

This would reduce side effects and limit the need for global chemotherapy.

Additional benefits would include a reduced risk of capsular contracture, allowing for fewer surgeries after reconstruction.

The Dox-eluting envelope would slowly and systematically continue releasing the drug, killing any cancer cells on site.

Help us take the next step in making this remarkable scientific innovation for cancer treatment a reality. All funds raised will go towards the clinical trial of this technology.

To learn more, visit www.bcif.us.